Risperidone 0.5 mg, 1 mg, 2 mg, and 3 mg tablets: Supply issue
There is a supply issue affecting Risperidone (Teva) tablets.
3 October 2024
From the week beginning 7 October 2024, Sandoz will supply stock of Risperidone Sandoz in 0.5, 1, 2 and 3 mg strengths. These will be listed in the Community Schedule from 4 October 2024 and the HML from 1 November 2024.
Affected product
There are supply issues affecting the follow presentations:
| Chemical | Brand | Presentation | Pharmacode | Subsidy | Measure/Qty |
|---|---|---|---|---|---|
| Risperidone | Risperidone (Teva) | Tab 0.5 mg | 2466899 | $2.17 | per 60 |
| Risperidone | Risperidone (Teva) | Tab 1 mg | 2466902 | $2.44 | per 60 |
| Risperidone | Rsperidone (Teva) | Tab 2 mg | 2466910 | $2.72 | per 60 |
| Risperidone | Risperidone (Teva) | Tab 3 mg | 2466929 | $4.50 | per 60 |
Schedule listing: Risperidone(external link)
Supply status of Risperidone Teva and Risperdal
At wholesalers:
- 0.5 mg – stock of Risperidone Teva available
- 1 mg – may be some stock available of the Risperdal tablets available
- 2 mg – may be some stock available of the Risperdal tablets available
- 3 mg – there is no stock available
- 4 mg – stock of Risperidone Teva available
The oral liquid and depot injections are unaffected by this supply issue.
Alternatives
Risperidone Sandoz
From 4 October 2024. Risperidone Sandoz will be listed in the Community Schedule (1 November for the HML). It will not appear in the Online Schedule until it is updated for 1 November. It is not Medsafe registered and will need to be prescribed and dispensed in line with section 29 of the Medicines Act.
| Chemical and presentation (60 pack) |
Price | Pharmacode |
|---|---|---|
| Risperidone tab 0.5 mg | $4.01 | 2693143 |
| Risperidone tab 1 mg | $3.68 | 2693151 |
| Risperidone tab 2 mg | $5.38 | 2693178 |
| Risperidone tab 3 mg | $8.57 | 2693186 |
For pharmacists
Listed with wastage claimable. The supplier advises that stock should be available for order in the week beginning 7 October 2024.
- RxOne users: the listing will be automatically updated by RxOne from the effective date.
- ScriptSense users: the listing will be automatically updated by ScriptSense from the effective date
- TONIQ users: the listing will automatically be updated in Toniq medicine databases from the effective date..
The Sector Operations Group will be able to process claims for October dispensing of the above listings. in October 2024.
- Risperidone Supply issue (Oct 24) A5 flier [PDF 197 KB]
Risperdal
Risperdal tablets have been listed, however there is limited availability of some strengths. People may also need to take multiple tablets to make up their dose.
We have created fliers to support pharmacists' conversations with people about the brand changes and changes to the number of tablets.
Medsafe datasheet for Risperdal(external link)
The oral liquid is also available in significant quantities. However people would need a new prescription.
Expected resupply
Resupply for Risperidal
- 1 mg tablets – expected late October 2024
- 2 mg tablets – expected November 2024
- 3 mg tablets – expected late October 2024
Resupply for Risperidone (Teva)
- 1 mg tablets – expected November 2024
- 2 mg tablets – expected November 2024
- 3 mg tablets – expected November 2024
- 4 mg tablets – expected November 2024
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)